Home/Filings/4/0000905148-24-000834
4//SEC Filing

Garren Hideki 4

Accession 0000905148-24-000834

CIK 0001559053other

Filed

Feb 28, 7:00 PM ET

Accepted

Feb 29, 9:01 PM ET

Size

5.7 KB

Accession

0000905148-24-000834

Insider Transaction Report

Form 4
Period: 2024-02-27
Garren Hideki
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-02-27+85,00085,000 total
    Exercise: $30.30Exp: 2034-02-27Ordinary Shares (85,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 27, 2025, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Documents

1 file

Issuer

PROTHENA CORP PUBLIC LTD CO

CIK 0001559053

Entity typeother

Related Parties

1
  • filerCIK 0001854126

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 9:01 PM ET
Size
5.7 KB